Literature DB >> 15562163

Abnormally high serum ferritin levels among professional road cyclists.

H Zotter1, N Robinson, M Zorzoli, L Schattenberg, M Saugy, P Mangin.   

Abstract

BACKGROUND: An international, longitudinal medical follow up examination of male professional road cyclists revealed excessively elevated serum ferritin levels.
OBJECTIVE: To evaluate the importance of elevated ferritin values among professional cyclists, their relationship with age and nationality, and their evolution over 3 years.
METHODS: Over 1000 serum ferritin values were collected. Other parameters were included in order to exclude conditions which might have increased ferritin levels without changing body iron stores.
RESULTS: In 1999, over 45% of riders displayed ferritin values above 300 ng/ml and one fourth levels over 500 ng/ml. These percentages had decreased to 27% and 9%, respectively, 3 years later, while the overall average, which was above the normal limits in 1999, had decreased by 33% in 3 years. Older cyclists had higher ferritin values than younger cyclists. There was also a relationship between ferritin levels and the nationality of the cyclists. Analysis of 714 riders in 2000 and 2002 showed only a slight and insignificant decrease in the mean ferritin value although those with initially elevated iron stores had a much greater decrease.
CONCLUSION: Professional road cyclists used excessive iron supplementation leading to high serum ferritin levels correlating with increased body iron stores. Although the situation progressively improved over 3 years, it remains worrying as increased body iron stores are related to health complications. Therefore, prevention in addition to the fight against doping should be a main goal of the UCI. Aggressive therapy for athletes with excessive ferritin values should be carried out at or before the end of their careers.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15562163      PMCID: PMC1724983          DOI: 10.1136/bjsm.2003.006635

Source DB:  PubMed          Journal:  Br J Sports Med        ISSN: 0306-3674            Impact factor:   13.800


  32 in total

1.  Hereditary hemochromatosis and cancer risk: more fuel to the fire?

Authors:  M A Mallory; K V Kowdley
Journal:  Gastroenterology       Date:  2001-11       Impact factor: 22.682

Review 2.  Body iron stores and coronary heart disease.

Authors:  Jing Ma; Meir J Stampfer
Journal:  Clin Chem       Date:  2002       Impact factor: 8.327

3.  Neutrophil impairment associated with iron therapy in hemodialysis patients with functional iron deficiency.

Authors:  S I Patruta; R Edlinger; G Sunder-Plassmann; W H Hörl
Journal:  J Am Soc Nephrol       Date:  1998-04       Impact factor: 10.121

4.  Increased cancer risk in a cohort of 230 patients with hereditary hemochromatosis in comparison to matched control patients with non-iron-related chronic liver disease.

Authors:  A L Fracanzani; D Conte; M Fraquelli; E Taioli; M Mattioli; A Losco; S Fargion
Journal:  Hepatology       Date:  2001-03       Impact factor: 17.425

Review 5.  Iron therapy and cardiovascular disease.

Authors:  J L Sullivan
Journal:  Kidney Int Suppl       Date:  1999-03       Impact factor: 10.545

6.  Iron status in Danes updated 1994. I: prevalence of iron deficiency and iron overload in 1332 men aged 40-70 years. Influence Of blood donation, alcohol intake, and iron supplementation.

Authors:  N Milman; L Ovesen; K Byg; N Graudal
Journal:  Ann Hematol       Date:  1999-09       Impact factor: 3.673

Review 7.  Iron absorption and transport.

Authors:  M E Conrad; J N Umbreit; E G Moore
Journal:  Am J Med Sci       Date:  1999-10       Impact factor: 2.378

8.  Catalytically active iron and bacterial growth in serum of haemodialysis patients after i.v. iron-saccharate administration.

Authors:  J Parkkinen; L von Bonsdorff; S Peltonen; C Grönhagen-Riska; K Rosenlöf
Journal:  Nephrol Dial Transplant       Date:  2000-11       Impact factor: 5.992

9.  The effect of intravenous iron on the reticulocyte response to recombinant human erythropoietin.

Authors:  A Major; F Mathez-Loic; R Rohling; K Gautschi; C Brugnara
Journal:  Br J Haematol       Date:  1997-08       Impact factor: 6.998

Review 10.  Iron supplementation in athletes. Current recommendations.

Authors:  P Nielsen; D Nachtigall
Journal:  Sports Med       Date:  1998-10       Impact factor: 11.136

View more
  6 in total

1.  Erythropoietin and blood doping.

Authors:  N Robinson; S Giraud; C Saudan; N Baume; L Avois; P Mangin; M Saugy
Journal:  Br J Sports Med       Date:  2006-07       Impact factor: 13.800

2.  Iron status in elite young athletes: gender-dependent influences of diet and exercise.

Authors:  Karsten Koehler; Hans Braun; Silvia Achtzehn; Ursula Hildebrand; Hans-Georg Predel; Joachim Mester; Wilhelm Schänzer
Journal:  Eur J Appl Physiol       Date:  2011-05-19       Impact factor: 3.078

Review 3.  Iron and atherosclerosis: nailing down a novel target with magnetic resonance.

Authors:  Travis P Sharkey-Toppen; Arun K Tewari; Subha V Raman
Journal:  J Cardiovasc Transl Res       Date:  2014-03-04       Impact factor: 4.132

4.  Iron Supplementation during Three Consecutive Days of Endurance Training Augmented Hepcidin Levels.

Authors:  Aya Ishibashi; Naho Maeda; Akiko Kamei; Kazushige Goto
Journal:  Nutrients       Date:  2017-07-30       Impact factor: 5.717

5.  Elevated Serum Hepcidin Levels during an Intensified Training Period in Well-Trained Female Long-Distance Runners.

Authors:  Aya Ishibashi; Naho Maeda; Daichi Sumi; Kazushige Goto
Journal:  Nutrients       Date:  2017-03-14       Impact factor: 5.717

6.  Influence of chronic training workload on the hematological profile: a pilot study in sedentary people, amateur and professional cyclists.

Authors:  Giuseppe Lippi; Fabian Sanchis-Gomar
Journal:  Acta Biomed       Date:  2020-11-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.